
Levonorgestrel - Impurity PCAS 100021-05-4
- Catalogue No.
- CSL-18898
- Alternative Cat. No.
- D229935
- CAS No.
- 100021-05-4
- Molecular formula
- C21H28O2
- Molecular weight
- 312.45
- Parent drug
- Levonorgestrel
- Product type
- Impurities, Pharmaceutical Reference Standards, Intermediates and building blocks, pharmaceutical standards, Fine Chemicals, steroids
Quick quote · CSL-18898Price and availability on request
ISO 17034:2016 · GLPTell us the quantity you need, from a few milligrams upwards, and we reply within 24 hours with price, availability and delivery time.
Need documents or a larger lot? Use the full quote form
Synonyms
- Δ5-Levonorgestrel
- 5(6)-Dehydro-4(5)-dihydro D-(-)-Norgestrel
- (17α)-13-Ethyl-17-hydroxy-18,19-dinorpregn-5-en-20-yn-3-one
Show all 6 synonyms
- Levonorgestrel-5-ene isomer
- 13-Ethyl-17-hydroxy-18,19-dinor-17α-pregn-5-en-20-yn-3-one (As per USP Commenting Opening 51(3))
- 5(6)-Dehydro-4(5)-dihydro D-(-)-Norgestrel (~90%)
More Levonorgestrel products
All 84 →![Chemical structure of (13S,17R)-6-Bromo-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F13S17R-6-Bromo-13-ethyl-17-ethynyl-17-hydroxy-1267891011121314151617-tetradecahydro-3H-cyclopentaaphenanthren-3-one.png&w=3840&q=75)
(13S,17R)-6-Bromo-13-ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-oneCSL-185049
![Chemical structure of (5S,8R,9S,13S,14S,17R)-13-Ethyl-17-ethynyl-17-hydroxy-2,4,5,6,7,8,9,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F5S8R9S13S14S17R-13-Ethyl-17-ethynyl-17-hydroxy-245678911121314151617-tetradecahydro-3H-cyclopentaaphenanthren-3-one.png&w=3840&q=75)
(5S,8R,9S,13S,14S,17R)-13-Ethyl-17-ethynyl-17-hydroxy-2,4,5,6,7,8,9,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-oneCSL-195591
![Chemical structure of (8R,9S,10R,13S,14S,17R,E)-13-Ethyl-17-ethynyl-17-hydroxy-8,9,10,11,12,13,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3(2H)-one oxime](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F8R9S10R13S14S17RE-13-Ethyl-17-ethynyl-17-hydroxy-891011121314151617-decahydro-1H-cyclopentaaphenanthren-32H-one-oxime.png&w=3840&q=75)
(8R,9S,10R,13S,14S,17R,E)-13-Ethyl-17-ethynyl-17-hydroxy-8,9,10,11,12,13,14,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3(2H)-one oximeCSL-175373
![Chemical structure of (8R,9S,10R,13S,14S,17S)-13-Ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F178737-52-5-8R9S10R13S14S17S-13-Ethyl-17-ethynyl-17-hydroxy-1267891011121314151617-tetradecahydro-3H-cyclopentaaphenanthren-3-one.png&w=3840&q=75)
(8R,9S,10R,13S,14S,17S)-13-Ethyl-17-ethynyl-17-hydroxy-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one178737-52-5

